Background/Aims: Camel milk (CM) has shown beneficial anti-inflammatory actions in several experimental and clinical settings. So far, its effect on rheumatoid arthritis (RA) has not been previously explored. Thus, the current work aimed to evaluate the effects of CM in Adjuvant-induced arthritis and air pouch edema models in rats, which mimic human RA. Methods: CM was administered at 10 ml/kg orally for 3 weeks starting on the day of Freund's adjuvant paw inoculation. The levels of TNF-α and IL-10 were measured by ELISA while the protein expression of NF-κBp65, COX-2 and iNOS was detected by immunohistochemistry. The expression of MAPK target proteins was assessed by Western blotting. Results: CM attenuated paw edema, arthritic index and gait score along with dorsal pouch inflammatory cell migration. CM lowered the TNF-α and augmented the anti-inflammatory IL-10 levels in sera and exudates of arthritic rats. It also attenuated the expression of activated NF-κBp65, COX-2 and iNOS in the lining of the dorsal pouch. Notably, CM inhibited the MAPK pathway signal transduction via lowering the phosphorylation of p38 MAPK, ERK1/2 and JNK1/2 in rat hind paws. Additionally, CM administration lowered the lipid peroxide and nitric oxide levels and boosted glutathione and total anti-oxidant capacity in sera and exudates of animals.
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune disease associated with robust synovial inflammation that culminates in destructive events in cartilage and bone along with bone outgrowths that restrict the mobility of joints [1] . Inflammation has been regarded as a cardinal player in the pathogenesis of arthritis. Within the inflamed joint compartment, a massive recruitment of immune cells, such as CD4 + T cells, B cells, macrophages and neutrophils has been detected. Mounting evidence revealed the role of proinflammatory cytokines such as TNF-α and IL-6 in creating self-perpetuating joint inflammation and articular destruction [2] [3] [4] . In contrast, low levels of the anti-inflammatory IL-10 have been detected in patients with RA [5] . Proinflammatory cytokines have been reported to activate several transcription factors that are intimately linked to the expression of inflammatory and catabolic signals. A prominent member of these transcription factors is the nuclear factor kappa B (NF-κB) which controls the expression of proinflammatory cytokines, including TNF-α itself, cyclo-oxygenase-2 (COX-2) linked with PGE 2 synthesis and inducible nitric oxide synthase (iNOS) associated with overshooting of nitric oxide (NO) in RA patients [6, 7] . Additionally, proinflammatory cytokines can activate several inflammatory transduction pathways, including mitogen activated protein kinase (MAPK). The MAPK family includes p38MAPK, extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), which have been reported to be activated in the synovium of RA patients [8, 9] .
The infiltration of immune cells to joints has been associated with marked production of reactive oxygen species (ROS) such as superoxide, hydrogen peroxide and hydroxyl radicals [10] . These mediators have been reported to mediate the progression of joint destruction in RA [7] . ROS have been implicated in the destructive oxidation of membrane lipids creating lipid peroxides, a hallmark of oxidative stress in RA. Additionally, increased levels of reactive nitrogen species (RNS) such as NO have been widely detected in serum and synovial fluid of RA patients [7, 10] .
The mainstay of therapy for RA includes glucocorticoids, biological therapy and disease modifying anti-rheumatic drugs (DMARDs) that were proven effective in the management of this ailment [11] . Yet, the adverse effects and the high cost of these agents during long therapy are considered major drawbacks. Thus, new therapeutic approaches, in particular with fewer side effects, are under investigation. Camel milk (CM) might represent a potential candidate. CM has displayed distinctive anti-oxidant properties due to its high content of vitamins C and E along with zinc and selenium. The high levels of lactoferrin in CM can explain its marked anti-inflammatory and anti-oxidant properties [12] . Furthermore, increased amounts of IgA, IgM and nano antibodies have been characterized in CM [13] . At the experimental and clinical settings, CM has been reported to exhibit protective and alleviating properties against diabetes [14] , diabetic nephropathy [15] , alcohol-induced hepatic injury [16] , steatohepatitis [17] and inflammatory bowel disease [18] . Furthermore, CM has shown favorable effects on the redox status and immune cells in diabetic mice [19] . Taken together, the marked anti-oxidant and anti-inflammatory features of CM encouraged us to investigate its efficacy in experimentally-induced RA.
Materials and Methods

Animals
Adult Wistar rats (200±20 g; King Fahd medical research center, Jeddah, KSA) were housed 4 per cage at constant temperature (25±2 °C), humidity (60±10%) and a 12/12 h light/dark cycle. Rats were provided with standard rat chow (15% protein, 3.5 % fat, 6.5% crude fibers plus vitamins/minerals mixture) and water ad libitum. Additionally, animals were acclimatized for 7 days before the start of experimental work. All efforts were made to maintain a clean environment for experiments. All procedures pertaining to the animal care and treatments were approved by the Research Ethical Committee of Taif University, Taif, Saudi Arabia and were strictly performed according to the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH publication No. 80-23, revised 1996).
Reagents and drugs
Freund Complete Adjuvant (FCA) was obtained from Difco laboratories, USA, whereas Diclofenac was from Sigma-Aldrich, USA. Other chemicals/solvents are of the highest analytical grade. Camel milk (CM) was obtained as a standardized CM product containing 3% fat and 6.3 % milk non-fat solids purchased from AlTurath Al-Saudia Company, Jeddah, KSA. Notably, the marked anti-inflammatory and antioxidant features of CM are considerably attributed to lactoferrin, an iron binding glycoprotein, which represents about 0.5% of total CM proteins (220 mg/L) [20, 21] .
Experimental design and treatment protocol.
To study the anti-arthritic effects of CM, two models of arthritis were investigated in the same rat; adjuvant-induced arthritis and subcutaneous (sc) air pouch edema. Adjuvant arthritis, an immune mediated immunopathy, mimics several features of RA [22] while the air pouch model closely approximates the human synovial cavity and its lining has marked resemblance to the synovium [23] . Moreover, the air pouch has the advantage of providing capacity for quantifying inflammatory mediators as well as exudative and cellular responses [24] .
To instigate arthritis in rats, 0.25 mg of heat-killed Mycobacterium butyricum (FCA) was inoculated subcutaneously into the plantar surface of left hind paw (day 0) as previously described [25] . To induce dorsal pouch edema, 10 days later, the back of the animal was shaved, cleansed with 70% ethanol and 20 ml of sterile air was subcutaneously injected under thiopental anesthesia (50 mg/kg; ip). On the 16 th day, the same dose of FCA was injected subcutaneously to the optimally responsive 6-day-old pouch [23] . At the end of the experimental period (day 21), animals were anaesthetized and pouch exudates and lining were harvested. Blood samples were obtained via retro-orbital plexus for whole blood and serum separation.
Forty rats were randomly divided into five groups (n=8). Group I (Control gp): normal rats, which received the vehicle only by oral route. Group II (Control + CM gp): normal rats that received Camel milk (CM; 10 ml/kg orally for 21 days). Group I and II also received sterile saline solution into the left hind paw on day zero. Group III (Arthritic gp): rats, which were rendered arthritic and received oral vehicle for 21 days. Group IV (Arthritic + CM): arthritic rats which received CM (10 ml/kg/day orally for 21 days). Group V (Arthritic + DF): arthritic rats which received the reference drug; diclofenac (5 mg/kg/day orally for 21 days). Diclofenac (in 0.5% carboxymethyl cellulose vehicle) and CM were administered by gavage daily starting two hours before injecting FCA on day 0 and were continued up to day 20.
The selected dose of CM is based on our preliminary experiments as well as previous studies reporting the efficacy of 10ml/kg oral dose in amelioration of experimental inflammatory bowel disease [18] , ethanolinduced hepatic injury [16] and lipopolysaccharide-evoked lung injury [26] . Diclofenac was chosen as a reference anti-inflammatory agent due to its proven anti-arthritic effects in Adjuvant-induced arthritis [27, 28] . Its selected dose is in accordance with previous literature [27, 28] . The chosen regimen is in accordance with previous reports [23, 29] .
Blood and air pouch exudates collection
At the end of the experimental period, rats were anesthetized and whole blood, serum and pouch exudates were collected as previously described [27] .
Increase in paw diameter
Using micrometer screw gauge, the dorso-plantar paw diameter was determined on days 0, 4, 8, 14, 19 and 21 following FCA inoculation as previously described [25] .
Arthritic index score
A semi-quantitative scoring system was used to express the severity of arthritis as previously reported [30] . A 0-4 score was used as described in Table 1 .
Gait scoring
The severity of pain resulting from arthritis was expressed using a 0-3 scoring system [31] as follows: 0, normal gait; 1, slight lameness; 2, lameness with weight bearing on toes only; 3, non-weight bearing animals.
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Histopathology and immunohistochemical detection of NF-κBp65, COX-2 and iNOS
A routine histopathology protocol was adopted as previously described [32] . In brief, air pouch lining specimens were harvested and fixed in 10% formalin for 24 h. Five micron paraffin embedded sections were stained with hematoxylin and eosin (H&E) and the slides were inspected under the light microscope (Leica Microsystems, Germany) by an observer unaware of sample identity.
For immunohistochemistry, 3-micron sections were placed in xylene and rehydrated in graded ethanol and finally blocked in 5% bovine serum albumin/ Tris buffered saline (TBS) [33] . Primary antibody incubation was performed overnight at 4 °C using rabbit polyclonal antibodies against NF-κBp65, COX-2 or iNOS (Thermo Scientific, IL, USA). Slides were washed with TBS and incubated with secondary antibody. Slides were finally incubated in 0.02% diaminobenzidine (DAB) containing 0.01% H 2 O 2 and counter stained with hematoxylin. Slides were examined under the light microscope (Leica Microsystems, Germany). Densitometric analysis of target protein expression was performed on the digital images using Image J software (Bethesda, USA).
Determination of TNF-α and IL-10
The serum and pouch exudate levels of tumor necrosis factor-α (TNF-α) and interleukin 10 (IL-10) were estimated as described [34] using specific ELISA kits purchased from R&D Systems, USA . All procedures were adopted as instructed by the manufacturer and absorbance was read at 450 nm (ELx800, BioTek, USA).
Western blotting
Soft tissues from rat hind paws were excised and immediately frozen. Then, they were homogenized in ice cold lysis buffer (2% SDS, 100mM Tris HCl) provided with a protease inhibitor and phosphatase inhibitor cocktail. Protein quantitation was performed using Biorad-DC protein assay kit (Biorad, USA). The Western blot protocol was performed as described [35, 36] . Aliquots containing equal protein amounts (30 μg) were separated by SDS-polyacrylamide gel electrophoresis (8% gel). The proteins were transferred to PVDF membranes which were probed overnight at 4 o C with specific primary antibodies: rabbit monoclonal antiphospho-p38MAPK (Thr180/Tyr182), rabbit monoclonal anti-p38MAPK, rabbit monoclonal anti-phospho-ERK1/2 (phospho-p44/42; Thr202/Tyr204)), rabbit monoclonal anti-ERK1/2 (p44/42), rabbit monoclonal anti-phospho-JNK1/2 (Thr 183/185), rabbit polyclonal anti-JNK1/2 and rabbit monoclonal anti-Lamin B (Cell Signaling Technology, USA). Membranes were washed 3 times in TBS/tween20, then, incubated with anti-rabbit IgG HRP-linked secondary antibody (Cell Signaling Technology, USA) for 1h. Following washing, membranes were incubated in Clarity Western ECL substrate (Biorad, CA, USA) and exposed to x-ray film. Equal protein loading was confirmed by probing with anti-Lamin B antibody. Densitometric analysis was performed by normalizing to total corresponding target protein and signals were quantified via Image J software (Bethesda, MD, USA).
Determination of lipid peroxides, NO, GSH and TAC
Serum and exudate lipid peroxides, expressed as malondialdehyde (MDA), were determined using thiobarbituric acid reaction according to Buege and Aust [37] . Nitric oxide (NO) levels were estimated based on the method of Miranda et al. [38] with the modification of replacing zinc sulfate instead of ethanol for protein precipitation [32] . The anti-oxidant defenses; reduced glutathione (GSH) and total anti-oxidant capacity (TAC) were determined according to the colorimetric method of Beutler et al. [39] and the specific TAC kit (Cayman, USA), respectively. 
Statistical analysis
Statistical analysis of parametric data (expressed as mean ± SEM) was performed using one-way analysis of variance (ANOVA), followed by Tukey-Kramer test for multiple comparisons between groups. The statistical significance for non-parametric data (expressed as median) was carried out using Kruskal-Wallis analysis of variance followed by the rank-based Mann-Whitney U-test for group comparisons. For both cases, SPSS programme, version 17, was utilized.
Results
Camel milk mitigates
Adjuvant-induced arthritis
The potential anti-arthritic actions of CM were studied with the aid of Adjuvantinduced arthritis model, a well recognized immune-mediated model of arthritis [22] . Injection of FCA into rats exhibited significant arthritis features as evidenced by a sharp increase in hind paw diameter on day 4 that continued till the end of the study (21 st day; Fig.  1A ). The animals also showed increased arthritic index scores revealing significant paw swelling and hyperemia involving the entire paw and ankle (Fig. 1B) . Additionally, (Fig. 1C) . Interestingly, CM mitigated the development of paw edema by 41%, 39%, 47% and 51% on the 8 th , 14 th , 19 th and 21 st day, respectively, as compared to the arthritic group. CM also attenuated the severity of arthritis as demonstrated by lowering of the arthritic index scores by 53.2% together with ameliorating the arthritic pain as seen by lowering of the gait scores by 60% inhibition, as compared to the arthritic group. These actions were similar to those afforded by the reference drug; diclofenac.
Camel milk attenuate pouch leukocyte influx and histopathologic alterations
Histopathology of the pouch lining from arthritic group revealed diffuse inflammatory cell infiltration through the entire membrane thickness with some focal areas of suppuration ( Fig. 2A) . The migration of immune cells and the histopathologic alterations were mitigated by CM and DF (Fig. 2B,C) . In this regard, lining from CM and DF groups displayed resolving areas of fibroblasts, whereas, that of DF was characterized with a dense granulation tissue. Additionally, injection of FCA into the sc pouch of pre-sensitized animals provoked a spike in infiltration of leukocytes as evidenced by detection of 21 ± 2.95 x 10 3 cells/mm 3 in dorsal exudates (Fig. 2D) . Administration of CM afforded 38.7% inhibition of leukocyte influx; an event that was similar to diclofenac that showed 46.7% inhibition.
Camel milk suppresses arthritis-associated inflammatory response
Injection of FCA resulted in a marked inflammatory response in arthritic rats as evidenced by a 5-fold increase in serum TNF-α together with lowering of the anti-inflammatory IL-10 levels (28.8%), as compared to control rats (Fig. 3) . The levels of the aforementioned cytokines in the exudate of arthritic animals were 257.8 ± 28.9 pg/ml and 71.6 ± 8.8 pg/ ml, respectively. Notably, CM resulted in a 29.6% and 39.7% inhibition of TNF-α in sera and exudates, respectively as compared to arthritic rats. Additionally, it normalized the serum levels of IL-10 and boosted the exudate levels by 197.4%.
Camel milk downregulates the protein expression of NF-κBp65, COX-2 and iNOS in pouch lining
To further characterize the inflammatory milieu of arthritic rats, the protein expression of activated NF-κBp65, COX-2 and iNOS, proinflammatory signals were detected in the dorsal pouch lining. Arthritic rats exhibited marked expression of activated NF-κB p65, COX2 and iNOS as manifested by intense brown staining of the relevant target proteins (Fig.  4-6 ). Administration of CM attenuated the expression of the three inflammatory proteins as demonstrated by 69.7%, 41.1%, and 36.7% inhibition of the optical density for NF-κBp65, COX-2 and iNOS expression, respectively. These mitigation patterns were similar to DF.
Camel milk suppresses activation of MAPK transduction in hind paws of arthritic rats
MAPK pathway plays a pivotal role in the development of inflammation and tissue destruction in RA [8, 9] . Western blot analysis revealed activation of MAPK signaling in hind paws of arthritic rats as seen by increased phosphorylation of p38MAPK, ERK1/2 and JNK1/2 proteins, compared to control rats (Fig. 7A) . CM inhibited the phosphorylation of the above MAPK proteins by 51.9%, 36.6% and 37.4%, respectively (Fig. 7B-D) . These actions were similar to DF. (C) Relative expression of phospho-ERK1/2. (D) Relative expression of phospho-JNK1/2. The control value was set as 1.0. Data were extracted from 3 independent experiments and values were expressed as mean ± SEM.*Significant difference vs control gp at p<0.05, # Significant difference vs arthritic gp at p<0.05. AA; Adjuvant arthritis, CM; Camel milk, DF; diclofenac.
Camel milk inhibits oxidative stress markers and augments the anti-oxidant defenses
To delineate the redox status of arthritic animals, the levels of lipid peroxides expressed as MDA and NO together with GSH and TAC were determined in the sera (or blood for GSH) 
and exudates of arthritic rats. Sera of arthritic rats showed a 3.9 and 4.7 fold rises in lipid peroxides and NO levels, respectively, with a concomitant decrease of blood GSH (60.3%) and TAC (71.9%), as compared to control group (Fig. 8) . Likewise, the exudates of arthritic animals revealed marked oxidative stress where significant levels of MDA (7.48 ± 0.88 μmol/L ), NO (157.7 ± 17.38 μmol/L), GSH (483.45 ± 72.4 μmol/L) and TAC (1.28 ± 0.15 mmol/L) were detected. In both sera and exudate of animals, CM alleviated the levels of MDA and NO and boosted the anti-oxidant GSH and TAC levels; events that were similar to DF actions.
Discussion
The current study reports, for the first time, the promising anti-arthritic actions of CM in immune-mediated Adjuvant arthritis and air pouch edema models that share several features of human RA. Adjuvant arthritis was used to delineate the systemic inflammatory responses triggered by FCA in animals whereas the air pouch edema model recapitulates the local events in RA synovial compartment [22, 23] . Our data revealed a robust inflammatory response in arthritic rats marked with elevated TNF-α levels and protein expression of activated NF-κB p65, COX-2 and iNOS proinflammatory signals. Additionally, the anti-inflammatory IL-10 levels were diminished. These findings are in concert with previous studies [5, 27] . Cytokines have been described for mediating the progression of arthritis [4, 40] . TNF-α triggers the release of ROS and drives osteoclastogenesis and the expression of matrix me- talloproteinases culminating in articular degradation [2, 3] . The observed decline in IL-10 may indicate severe inflammatory response in arthritic rats since IL-10 serves as an antiinflammatory signal which attenuates the release of proinflammatory cytokines from activated macrophages and neutrophils [5] . The pathogenesis of RA also involves activation of NF-κB pathway which plays a central role in inflammation, hyperalgesia and tissue injury in RA [6] . Driven by ROS and diverse cytokines, activated NF-κB is involved in the transcription of several proinflammatory genes including COX-2, iNOS and TNF-α under a pro-oxidant environment [41] . Following degradation of the inhibitory IκB subunit, active NF-κB heterodimer (p50 and p65 subunits) translocates to the nucleus to regulate target genes transcription. Thus, activated NF-κBp65 has been classically regarded as an activation index for NF-κB [40] . In RA patients, intense expression of COX-2, induced by proinflammatory cytokines, has been described in synovium lining cells, fibroblasts and macrophage with consequent overshooting of PGE 2 . The synovium-resident cells also display an enhanced iNOS expression which is driven by NF-κB and several cytokines including TNF-α [7] . Virtually, iNOS plays a crucial role in mediating irreversible bone erosion in the joints of RA patients probably via stimulation of bone osteoclast activity [7, 40] . The present findings revealed that CM exerted marked anti-inflammatory effects as evidenced by downregulation of TNF-α, COX-2, iNOS and their upstream effector NF-κB together with augmenting the IL-10 anti-inflammatory signal. These multipronged antiinflammatory mechanisms are in accord with previous reports that described CM marked anti-inflammatory actions in several experimental models [16, 26, 42] . A prominent antiinflammatory component of CM is the lactoferrin protein which has been characterized to abrogate TNF-α, IL-1 and IL-6 in mononuclear cells in vitro and in vivo in response to LPS stimulation. Lactoferrin has been also reported to enhance the levels of IL-10 in a rat model of colitis [12] . The observed downregulation of activated NF-κB p65 in pouch lining confirms the effective anti-inflammatory actions of CM [43] . Meanwhile, the observed downregulation of TNF-α, COX-2 and iNOS in arthritic rats is likely due to inhibition of their upstream NF-κB transcription factor [7, 40] .
The current findings demonstrated that Adjuvant arthritis triggered the activation of p38, ERK 1/2 and JNK 1/2 MAPKs in hind paws of animals, events which are in harmony with previous literature [40] . In fact, the three MAPKs have been identified to play a key role in the regulation of cytokine, chemokine and prostaglandin synthesis. Dysregulated activation of MAPKs has been implicated in RA pathogenesis, so, MAPKs can serve as pivotal molecular targets for therapeutic intervention [8, 9] . Activation of p38 MAPK contributes to RA pathogenesis via driving the expression of adhesion proteins in inflammatory cells and through generation of TNF-α [9] . The ERK family is involved in macrophage generation of TNF-α and COX-2-dependent production of PGE 2 in RA human fibroblast like synoviocytes [8] . A crucial role of JNK in RA pathogenesis is through matrix metalloproteinases(MMPs)-mediated cartilage degradation [8, 9] . Interestingly, administration of CM attenuated the activation of the three MAPKs. These data indicate that the suppression of MAPK activation is, at least partly, involved in CM alleviation of AA in rats. In fact, a previous study by Zhu et al. [26] described the efficacy of CM for downregulation of MAPK pathway in LPS-evoked respiratory distress in rats.
The current data affirmed the systemic and local oxidative stress marked with increased lipid peroxides and NO with concomitant decline of GSH and TAC anti-oxidant defenses. These findings are in line with previous reports [27, 29] . Virtually, aberrant generation of ROS and RNS by activated neutrophils and macrophages causes damage to joints likely via upregulation of MMPs and stimulation of osteoclast activity [7] . Lipid peroxides can trigger joint damage via releasing lysosomal enzyme into synovial cavity with resultant exacerbation of arthritis [7] . Within RA synovial compartment, excessive production of NO by iNOS-expressing macrophages and fibroblasts has been characterized [7] . NO reacts with superoxide anion to generate peroxynitrite, a robust oxidizing agent that instigates DNA fragmentation and lipid peroxidation [44] . The observed decline of GSH level is probably due to its consumption during detoxification of peroxides e.g., H 2 O 2 via the action of glutathione peroxidase [27, 45] .
The current data revealed that CM suppressed local and systemic oxidative stress and boosted the GSH and TAC anti-oxidant defenses. These findings support the premise that CM anti-oxidant actions are involved in the attenuation of immune-mediated arthritis. The powerful anti-oxidant activity of CM has been partly implicated in the mitigation of tissue damage in several experimental models [14-16, 18, 46] . Agents with marked anti-oxidant actions have been reported to curb the inflammatory events in experimental RA [5, 27, 40] . CM has displayed distinctive anti-oxidant properties owing to its high content of vitamins C and E along with zinc, selenium and other trace elements [47, 48] . The high content of lactoferrin in CM efficiently scavenges free iron in damaged tissues and abrogates the production of hydroxyl radicals [12, 49] . A likely explanation for the mitigation of the redox imbalance is secondary to the observed abrogation of leukocyte influx [27] . In the same context, a major factor for blunting oxidative stress is the observed inhibition of MAPK and NF-κB pathways [40] . The CM lowering of NO overshooting is possibly due to the observed downregulation of iNOS along with its upstream effector NF-κB [27, 40, 50] .
Conclusion
In conclusion, the current study has described the anti-inflammatory actions of CM in Adjuvant arthritis and air pouch edema models in rats. These promising effects were mainly linked to the inhibition of MAPK pathway, which controls the synthesis of proinflammatory signals. Thus, the current data may show the interest of CM consumption as an adjunct approach for the management of RA. Since the marked antioxidant/ anti-inflammatory actions of CM are essentially ascribed to lactoferrin [12, 49] , future studies are warranted to correlate the amount of lactoferrin in CM to the anti-arthritic activity. Further studies are also needed to establish the efficacy of CM in the clinical setting.
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